Related Experiment Video
Updated: May 25, 2026
08:45
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Hepcidin and iron homeostasis.
1Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. TGanz@mednet.ucla.edu
Biochimica Et Biophysica Acta
|February 7, 2012
Summary
The hormone hepcidin controls iron levels in the body by regulating intestinal absorption and iron distribution. Dysregulation of hepcidin causes iron disorders like anemia and overload.
Area of Science:
- Cell Biology
- Physiology
- Metabolism
Background:
- Plasma iron concentrations are tightly regulated despite dietary fluctuations and losses.
- Hepatic hepcidin is the central systemic iron-regulatory hormone.
- Hepcidin controls iron distribution by degrading ferroportin, the cellular iron exporter.
Purpose of the Study:
- To elucidate the regulatory mechanisms of hepcidin synthesis and its role in iron homeostasis.
- To explore the implications of hepcidin-ferroportin axis in iron-related disorders.
Main Methods:
- Review of existing literature on iron metabolism and hepcidin regulation.
- Analysis of the molecular complex regulating hepcidin synthesis.
- Examination of hepcidin's role in various physiological and pathological conditions.
Main Results:
- Hepcidin synthesis is regulated by iron levels and erythroid requirements.
- Hepcidin production is influenced by inflammation, impacting iron redistribution.
- Abnormal hepcidin levels are linked to anemias and iron overload disorders.
Conclusions:
- Hepcidin and ferroportin are critical regulators of iron homeostasis.
- Targeting the hepcidin-ferroportin pathway offers potential for diagnosing and treating iron disorders.
- Understanding hepcidin's complex regulation is key to managing iron metabolism.
More Related Videos
Related Concept Videos
01:24Microbes and Other Elemental Cycles
Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:21Hepatic Portal System
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
01:17Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...